Digital Treatment for Migraines - a Feasibility Study

Migraine Without Aura Clinical Trial

Official title:

Personalised Internet-based Treatment From a Biopsychosocial Perspective for Migraine Patients and Its Feasibility in Primary Care

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05018572
• Other study ID #: VGFOUSA-963615
• Status: Completed
• Phase: N/A
• Start date: July 1, 2021
• Est. completion date: October 14, 2022

Study information

• Verified date: October 2022
• Source: Vastra Gotaland Region
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

An individualised internet-based treatment from a biopsychosocial perspective for patients with migraines in primary care has been developed within the Vastra Gotaland region in 2019. The treatment program is called Learning to live with migraines, and goes by the acronym "I am" (Internet Approach to Migraine). In a pilot study, the treatment programme and its feasibility in primary care will be evaluated. It is hoped that the intervention "I am" can educate patients about their illness and help the patient manage migraine attacks so that the likelihood of difficulty and frequency of migraine attacks does not increase, as well as provide an increased function and quality of life.

Description:

Purpose The overall purpose of the study is to evaluate in a pilot study the practical feasibility of a future randomized study to evaluate personalized digital biopsychosocial treatment method, "I am"- Learning to live with migraines in primary care.

Issues

Will a large or small percentage of individuals who are asked to participate in the study accept participation? Will the random advantage to the different groups make potential participants hesitant? Will measuring the effect be practicable? What investigative instruments are appropriate in this situation? Is a new investigative instrument to be built? Are the interventions reasonable to apply given the resources we can expect to have in a larger study? Will a large or small proportion of patients discontinue participation in the study for various reasons? How common are unforeseen problems (which may justify the exclusion of a patient or the negative/harmful effects of the intervention)? What change in endpoints is seen in the different groups?

Recruitment information / eligibility

• Status: Completed
• Enrollment: 29
• Est. completion date: October 14, 2022
• Est. primary completion date: October 14, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Women and men

• Age18 to 65

• Diagnosis migraine with (G43.0) or without aura (G43.1)

• 3-15 migraine days a month

• Access to computer/tablet or smartphone with bankid and internet connection

Exclusion Criteria:

• Ongoing malignant disease

• Other migraine diseases

• Moderate to severe psychiatric problems such as depression or anxiety disorder

• Neuropsychiatric conditions

• Psychosis disorders

• Addiction

• Personality disorders

• People who cannot read, speak or understand the Swedish language

• Ongoing psychological/psychotherapeutic treatment

Related Conditions & MeSH terms

• Migraine Disorders
• Migraine With Aura
• Migraine Without Aura

Intervention

Behavioral:
• I AM
"I am" has a biopsychosocial perspective with a focus on pain management in migraines. The cognitive behavioural interventions being tested are Mindfulness, Acceptance and Commitment Therapy (ACT), Compassion Focused Therapy and Physiotherapist-led cardiotherapy. The treatment program consists of ten modules of texts, animated films with a fictional person to identify with, recorded audio exercises adapted for patients with migraines and filmed physiotherapeutic exercises with physiotherapists.The interventions in "I am" are personalised in that the first three modules and module 10 are for those who are being helped by a shorter treatment. The other modules, four to ten, are a more in-depth treatment for those who have frequent or chronic migraines. The participants are in contact with processors via message function as well as via phone at startup, at the middle of treatment and termination. The duration of treatment is 4-10 weeks.

Locations

Country	Name	City	State
Sweden	FoU primary care Södra Älvsborg	Boras	Sven Eriksonsplatsen 4

Sponsors (1)

Lead Sponsor	Collaborator
Vastra Gotaland Region

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Migraine Diary - change through week 2-10, and to 3 months follow up	Frequency and severity of migraine attacks monthly: will take place via a Migraine Diary. Questions to answer; Migraine pain signal?; When, day and time?; Where does it hurt? Tick: Right temple, Left temple, Neck Inside the head, Area around the eye , other; How's the pain? (Pulsating, burning, stinging, idling, stabbing); Strength, pain? (0-10); discomfort? (0-10); How do I try to deal with the pain? What emergency medication did you take at the beginning of the migraine attack?; How long did the migraine attack last?; Pain peak (throughout migraine attack) 0-10; In total, how much emergency medicine have you taken throughout the migraine attack?; Pre symptoms or other symptoms?	Week 2-10 through the study and by 3 months follow up. The participant fills in a new form of the diary for each new attack.
Primary	Employment rate - change through week 1, week 10, and by 3 months follow up	Employment rate: measured in percent by questions put to the participant.	Week 1, week 10 and by 3 months follow up
Primary	Bulls eye - activation in valued direction -change through week 1 and week 10, and to 3 months follow up	Measured with a Swedish version of Bulls eye (Lundgren, Louma, Dahl, Strohsal & Melin, 2012). ) The self-assessment scale is divided into four value areas in people's lives: work/education, leisure, relationships and self-care/health. The instrument has demonstrated a test-retest reliability of 0.86 and good criterion validity (Lundgren, Dahl & Hayes, 2008)	Week 1-10 through the study and by 3 months follow up
Secondary	Mental Health Continuum Short Form - Mental health and quality of life	Measured with Mental Health Continuum Short Form (MHC-SF). The self-assessment form consists of 14 questions that focus on emotional, psychological and social well-being and are considered to have good psychometric properties (Keyes, 2005).	Week 1 and week 10 and by 3 months follow up
Secondary	CORE-10 - A broader measure of mental health in terms of well-being, symptoms, function and risks	Measured with the Swedish version CORE-10. The self-assessment form consists of 10 questions, one of which measures suicidality (Elfström, M. L., Evans, C., Lundgren, J., Johansson, B., Hakeberg, M., & Carlsson, S. G. (2012).; Validation of the Swedish version of the Clinical Outcomes in Routine Evaluation Outcome Measure (CORE). Clinical Psychology and Psychotherapy. Epub ahead of print. doi:10.1002/cpp.1788)	Week 1 and week 10 and by 3 months follow up
Secondary	Self-Efficacy for Exercise Scale - in their ability to conduct physical exercise	Measured by the Swedish version of the Self-Efficacy for Exercise Scale (SEE-EN). The form contains nine questions about the patient's faith in broad physical activity under different circumstances. A sum is calculated between 0 and 90, where higher number means higher confidence.Resnick B, Jenkins L 2000 Testing the reliability and validity of the Self-efficacy for Exercise Scale. Nursing Research 49: 149-159).The form has been translated into Swedish and tested for validity and reliability for patients with heart disease (Cavrak A 2010 Test of the psychometric properties of the Swedish version of the Self-Efficacy for Exercise scale for patients in cardiac rehabilitation.; Masters Thesis, Uni-versity of Gothenberg.) And patients with long-term pain (Dahlbäck A, Andréll P, Varkey E. Reliability and Validity of the Swedish Version of the Self-Efficacy for Exercise Scale (SEE-SV) for Patients with Chronic Pain .2020 Unpublished manuscript).	Week 1, week 5, week 10 and by 3 months follow up
Secondary	Five Facet Mindfulness Questionnaire - conscious	Measured using the Swedish version of the Five Facet Mindfulness Questionnaire (FFMQ_SWE). FFMQ originally created by Baer et al. (2006) is a self-assessment form that aims to measure the ability to conscious presence. FFMQ_SWE consists of 29 claims and can be estimated between 1-5 points. The higher the score, the higher the self-rated ability to conscious presence. The internal validity and reliability of FFMQ_SWE is good (Lilja et al., 2011).	Week 1, week 5, week 10 and by 3 months follow up
Secondary	Self-Compassion Scale - Self compassion	Measured with Self-Compassion Scale - Short Form (SCS-SF). SCS-SF consists of 12 statements and is an abbreviated version of Self compassion scale (Neff, KD (2003b). The development and validation of a scale to measure self-compassion. Self & Identity, 2 (3), 223-250. doi: 10.1080 / 15298860309027. Self-compassion is measured with a corpse scale between 1 (almost never) and 5 (almost always) and has 6 subscales. SCS-SF has been shown to have good internal consistency (a = .86) and constructivevalidity as it correlates positively with SCS (r = 0.97). However, the subscale score has been shown to have poorer internal consistency and SCS-SF is therefore only suitable for measuring general self-compassion (Raes et al., 2011). Swedish translation of SCS-SF has been shown to have moderate internal consistency (a = .68) (Almqvist & Johansson, 2016).	Week 1, week 5, week 10 and by 3 months follow up
Secondary	Exercise diary, condition	Cardio training is measured with exercise diary Exercise diary contains filling in; activity, date, set	Week 1-10 through the study and by 3 months follow up
Secondary	Two questions to Haskell 2007 - Physical activity	Physical activity issues according to Haskell 2007. Two questions. Five total points or more means that the physical activity level is considered regular and corresponds to the public health recommendation. Below 5 total points means that the physical activity level needs to be increased.	Week 1-10 through the study and by 3 months follow up
Secondary	Acceptance of the treatment	Measured with its own constructed form developed for the study. The form consists of four questions: Would you recommend the processing to someone else? How meaningful have you experienced the treatment scale 1-7, as well as two open questions answered in writing: what have you got out of the treatment? What has been less good about the treatment?	Week 10 and by 3 months follow up